STOCK TITAN

[6-K] GSK plc Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

GSK plc filed a Form 6-K reporting transaction notifications. The filing lists share transactions with an ISIN GB00BN7SWP63 at a price of 3.0300 and multiple entries for ISIN US37733W2044 at a price of $40.7387. The document repeats the US ISIN and price across several lines and provides an aggregated section header, but it does not disclose volumes, the parties to the transactions, transaction types, or any explanatory context. The filing is dated September 22, 2025.

GSK plc ha presentato un Modulo 6-K che segnala notifiche di transazione. La compilazione elenca transazioni azionarie con un ISIN GB00BN7SWP63 al prezzo di 3.0300 e multiple voci per ISIN US37733W2044 al prezzo di $40.7387. Il documento ripete l’ISIN statunitense e il prezzo in diverse righe e fornisce un’intestazione di sezione aggregata, ma non rivela volumi, le controparti delle transazioni, i tipi di transazione o alcun contesto esplicativo. La pratica è datata 22 settembre 2025.

GSK plc presentó un Formulario 6-K que informa notificaciones de transacción. La presentación lista transacciones de acciones con un ISIN GB00BN7SWP63 a un precio de 3.0300 y varias entradas para ISIN US37733W2044 a un precio de $40.7387. El documento repite el ISIN estadounidense y el precio en varias líneas y ofrece un encabezado de sección agregado, pero no divulga volúmenes, las partes de las transacciones, tipos de transacción ni ningún contexto explicativo. La presentación tiene fecha 22 de septiembre de 2025.

GSK plc가 거래 알림을 보고하는 Form 6-K를 제출했습니다. 제출서에는 ISIN GB00BN7SWP63가 있는 주식 거래가 3.0300의 가격으로, 그리고 ISIN US37733W2044가 있는 다수의 항목이 $40.7387의 가격으로 기재되어 있습니다. 문서는 미국 ISIN과 가격을 여러 줄에 걸쳐 반복하고 집계 섹션 머리글을 제공하지만, 거래량, 거래 당사자, 거래 유형, 혹은 설명적 맥락은 공개하지 않습니다. 제출일은 2025년 9월 22일입니다.

GSK plc a déposé un formulaire 6-K signalant des notifications de transactions. Le dossier répertorie des transactions d’actions avec un ISIN GB00BN7SWP63 à un prix de 3,0300 et plusieurs entrées pour le ISIN US37733W2044 à un prix de $40,7387. Le document répète l’ISIN américain et le prix sur plusieurs lignes et fournit un en-tête de section agrégé, mais il ne divulge ni les volumes, ni les parties aux transactions, ni les types de transaction, ni aucun contexte explicatif. Le dépôt est daté du 22 septembre 2025.

GSK plc hat ein Form 6-K eingereicht, das Transaktionsbenachrichtigungen meldet. Die Einreichung listet Aktientransaktionen mit einem ISIN GB00BN7SWP63 zu einem Preis von 3.0300 und mehrere Einträge für ISIN US37733W2044 zu einem Preis von $40.7387. Das Dokument wiederholt die US-ISIN und den Preis über mehrere Zeilen und gibt eine aggregierte Abschnittsüberschrift an, offenbart jedoch weder Volumen, noch Parteien der Transaktionen, noch Transaktionstypen oder einen erläuternden Kontext. Die Einreichung ist datiert auf 22. September 2025.

GSK plc قدمت نموذج 6-K يقر بالإشعارات بالمعاملات. يسرد الملف معاملات أسهم مع ISIN GB00BN7SWP63 بسعر 3.0300 وبصرياً وجود عدة إدخالات لـ ISIN US37733W2044 بسعر $40.7387. يعيد المستند تكرار US ISIN والسعر عبر عدة أسطر ويقدم رأس قسم مجمع، ولكنه لا يكشف عن الأحجام، أو الأطراف المشاركة في المعاملات، أو أنواع المعاملات، أو أي سياق توضيحي. تاريخ التقديم 22 سبتمبر 2025.

GSK plc 提交了一份 Form 6-K,报告交易通知。该文件列出带有 ISIN GB00BN7SWP63 的股票交易,价格为 3.0300,以及多条涉及 ISIN US37733W2044 的记录,价格为 $40.7387。该文件在多行中重复了美国 ISIN 和价格,并提供了一个聚合的分段标题,但未披露成交量、交易方、交易类型或任何解释性背景。提交日期为 2025 年 9 月 22 日

Positive
  • None.
Negative
  • None.

GSK plc ha presentato un Modulo 6-K che segnala notifiche di transazione. La compilazione elenca transazioni azionarie con un ISIN GB00BN7SWP63 al prezzo di 3.0300 e multiple voci per ISIN US37733W2044 al prezzo di $40.7387. Il documento ripete l’ISIN statunitense e il prezzo in diverse righe e fornisce un’intestazione di sezione aggregata, ma non rivela volumi, le controparti delle transazioni, i tipi di transazione o alcun contesto esplicativo. La pratica è datata 22 settembre 2025.

GSK plc presentó un Formulario 6-K que informa notificaciones de transacción. La presentación lista transacciones de acciones con un ISIN GB00BN7SWP63 a un precio de 3.0300 y varias entradas para ISIN US37733W2044 a un precio de $40.7387. El documento repite el ISIN estadounidense y el precio en varias líneas y ofrece un encabezado de sección agregado, pero no divulga volúmenes, las partes de las transacciones, tipos de transacción ni ningún contexto explicativo. La presentación tiene fecha 22 de septiembre de 2025.

GSK plc가 거래 알림을 보고하는 Form 6-K를 제출했습니다. 제출서에는 ISIN GB00BN7SWP63가 있는 주식 거래가 3.0300의 가격으로, 그리고 ISIN US37733W2044가 있는 다수의 항목이 $40.7387의 가격으로 기재되어 있습니다. 문서는 미국 ISIN과 가격을 여러 줄에 걸쳐 반복하고 집계 섹션 머리글을 제공하지만, 거래량, 거래 당사자, 거래 유형, 혹은 설명적 맥락은 공개하지 않습니다. 제출일은 2025년 9월 22일입니다.

GSK plc a déposé un formulaire 6-K signalant des notifications de transactions. Le dossier répertorie des transactions d’actions avec un ISIN GB00BN7SWP63 à un prix de 3,0300 et plusieurs entrées pour le ISIN US37733W2044 à un prix de $40,7387. Le document répète l’ISIN américain et le prix sur plusieurs lignes et fournit un en-tête de section agrégé, mais il ne divulge ni les volumes, ni les parties aux transactions, ni les types de transaction, ni aucun contexte explicatif. Le dépôt est daté du 22 septembre 2025.

GSK plc hat ein Form 6-K eingereicht, das Transaktionsbenachrichtigungen meldet. Die Einreichung listet Aktientransaktionen mit einem ISIN GB00BN7SWP63 zu einem Preis von 3.0300 und mehrere Einträge für ISIN US37733W2044 zu einem Preis von $40.7387. Das Dokument wiederholt die US-ISIN und den Preis über mehrere Zeilen und gibt eine aggregierte Abschnittsüberschrift an, offenbart jedoch weder Volumen, noch Parteien der Transaktionen, noch Transaktionstypen oder einen erläuternden Kontext. Die Einreichung ist datiert auf 22. September 2025.

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of September 2025
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
79 New Oxford Street, London, WC1A 1DG
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
GSK plc (the 'Company')
Transaction notification
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Wendy Becker
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
 
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Purchase of 526 Ordinary Shares
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
£15.0300
526
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Elizabeth (Liz) McKee Anderson
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
 
240
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Charles Bancroft
 
b)
Position/status
Senior Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 1,880 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
1,880
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Hal Barron
 
b)
Position/status
Non-Executive Director
 
c)
Initial notification/ amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
$40.7387
240
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Anne Beal
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
  
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
240
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Hal Dietz
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
240
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume
 
Price
 
 
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Jeannie Lee
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 239 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
239
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Vishal Sikka
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 827 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
827
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: September 22, 2025
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc

FAQ

What did GSK (GSK) disclose in the Form 6-K dated September 22, 2025?

The Form 6-K discloses transaction notifications showing ISIN GB00BN7SWP63 at 3.0300 and multiple entries for ISIN US37733W2044 at $40.7387. No volumes or counterparties are provided.

Does the filing state the number of shares traded for GSK transactions?

No. The filing lists prices for the ISINs but does not disclose any aggregated volumes or individual trade quantities.

Which ISINs are mentioned in GSK's 6-K and at what prices?

The filing mentions GB00BN7SWP63 at 3.0300 and US37733W2044 repeatedly at $40.7387.

Is there information about the nature of the transactions in the 6-K?

No. The document labels entries as "Nature of the transaction" but does not provide specific transaction types or descriptions.

When was the Form 6-K filed for GSK?

The document is dated September 22, 2025.

GSK PLC

NYSE:GSK

GSK Rankings

GSK Latest News

GSK Latest SEC Filings

GSK Stock Data

87.92B
2.03B
0.06%
19.09%
0.55%
Drug Manufacturers - General
Healthcare
Link
United Kingdom
London